Ketogenic Diet for Neonatal Hypoxic-Ischemic Encephalopathy

Area of Science:

• Neurology
• Metabolic Disorders
• Pediatric Medicine

Background:

• Neonatal hypoxic-ischemic encephalopathy (HIE) is an increasing cause of neurological injury requiring new treatments.
• The ketogenic diet (KD) offers a cost-effective, safe therapeutic approach for various neurological conditions.
• The KD's mechanisms in brain injury, including energy metabolism and inflammation, are under investigation.

Purpose of the Study:

• To review the role of the ketogenic diet (KD) in treating neonatal hypoxic-ischemic encephalopathy (HIE).
• To describe the protective mechanisms of ketone bodies (KBs) in pathological brain conditions.
• To evaluate the evidence supporting dietary interventions for HIE.

Main Methods:

• Literature review of studies on ketogenic diet and hypoxic-ischemic encephalopathy.
• Analysis of proposed mechanisms of action for ketone bodies in brain injury.
• Synthesis of evidence from animal models and human studies.

Main Results:

• The ketogenic diet (KD) demonstrates potential benefits in animal models and some human brain injury cases.
• Ketone bodies (KBs) may offer an alternative energy source, improve mitochondrial function, and reduce inflammation and apoptosis.
• The efficacy of KD varies, highlighting the need for further investigation into its effects on neuronal damage, motor, and cognitive functions.

Conclusions:

• The ketogenic diet (KD) presents a promising therapeutic strategy for neonatal hypoxic-ischemic encephalopathy (HIE).
• Evidence supports exploring dietary interventions, specifically the KD, for HIE treatment.
• Future research must clarify the KD's mechanisms in HIE patients and validate its clinical efficacy in humans.